(Q37419064)

20 August 2017

1 reference

title

Neuroprotection and neuroregeneration in multiple sclerosis (English)

1 reference

20 August 2017

0 references

Martin Stangel

1

1 reference

20 August 2017

publication date

1 December 2008

1 reference

20 August 2017

1 reference

20 August 2017

volume

255 Suppl 6

1 reference

20 August 2017

page(s)

77-81

1 reference

IV immunoglobulin does not reverse established weakness in MS.

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-008-6014-X

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

21 January 2018

1 reference

12 December 2020

Remyelination protects axons from demyelination-associated axon degeneration

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex

1 reference

12 December 2020

Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?

1 reference

12 December 2020

A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis

1 reference

12 December 2020

Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice

1 reference

12 December 2020

Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation

1 reference

12 December 2020

Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination.

1 reference

12 December 2020

Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease

1 reference

12 December 2020

Notch1 control of oligodendrocyte differentiation in the spinal cord

1 reference

12 December 2020

Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine

1 reference

12 December 2020

A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis

1 reference

12 December 2020

Remyelination is extensive in a subset of multiple sclerosis patients.

1 reference

12 December 2020

Humoral autoimmunity as a mediator of CNS repair

1 reference

12 December 2020

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

12 December 2020

Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21

1 reference

12 December 2020

From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases

1 reference

12 December 2020

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

1 reference

12 December 2020

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

1 reference

12 December 2020

Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination.

1 reference

12 December 2020

Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status

1 reference

12 December 2020

Astrocytes promote myelination in response to electrical impulses

1 reference

12 December 2020

Imaging of CNS myelin by positron-emission tomography

1 reference

12 December 2020

LINGO-1 negatively regulates myelination by oligodendrocytes

1 reference

12 December 2020

Role for CXCR2 and CXCL1 on glia in multiple sclerosis

1 reference

12 December 2020

Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches

1 reference

12 December 2020

Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system

1 reference

12 December 2020

Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination

1 reference

12 December 2020

Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis.

1 reference

12 December 2020

1 reference

12 December 2020

Dissecting demyelination

1 reference

12 December 2020

Electron microscopic features of multiple sclerosis lesions

1 reference

12 December 2020

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

1 reference

12 December 2020

A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients.

1 reference

12 December 2020

Extensive cortical remyelination in patients with chronic multiple sclerosis.

1 reference

12 December 2020

Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis

1 reference

12 December 2020

The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study

1 reference

12 December 2020

Remyelinating and neuroprotective treatments in multiple sclerosis

1 reference

12 December 2020

CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.

1 reference

12 December 2020

Viral induced demyelination

1 reference

12 December 2020

10.1007/S00415-008-6014-X

Identifiers

DOI

1 reference

20 August 2017

1 reference